Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8

Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8–13

Published:2006-05 Issue:4 Volume:33 Page:505-512
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Zhang Kaijun,An Rui,Gao Zairong,Zhang Yongxue,Aruva Mohan R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference35 articles.

1. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog;Thakur;J Nucl Med,2004

2. Neurotensin regulates growth of human pancreatic cancer;Ishizuka;Ann Surg,1993

3. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma;Reubi;Gut,1998

4. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas;Terriere;Int J Cancer,1999

5. Neurotensin and neurotensin receptors;Vincent;Trends Pharmacol Sci,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-21

2. Technetium(I) carbonyl complexes for nuclear medicine: Coordination-chemical aspect;Coordination Chemistry Reviews;2023-02

3. Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities;European Journal of Medicinal Chemistry;2021-10

4. Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with 68Ga and 177Lu as Potential Theranostic Agent for Colon Cancer;Pharmaceutics;2021-04-07

5. Tumor targeting with99mTc radiolabeled peptides: Clinical application and recent development;Chemical Biology & Drug Design;2018-10-30